MICHAEL YEN to Neuromuscular Agents
This is a "connection" page, showing publications MICHAEL YEN has written about Neuromuscular Agents.
Connection Strength
1.145
-
Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm". Ophthalmic Plast Reconstr Surg. 2014 Jan-Feb; 30(1):76-7.
Score: 0.404
-
Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis. Ann Plast Surg. 2008 Jan; 60(1):6-9.
Score: 0.267
-
Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids. Ophthalmic Plast Reconstr Surg. 2007 Jan-Feb; 23(1):22-4.
Score: 0.249
-
Chemodenervation for the Treatment of Facial Dystonia: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018 09; 125(9):1459-1467.
Score: 0.136
-
Botulinum toxin injection for the management of refractory filamentary keratitis. Arch Ophthalmol. 2012 Apr; 130(4):446-50.
Score: 0.089